thanks Izzy i think i read this article. i am just feeling a bit desperate that there should not be any delays. i feel UK should approve straightaway on basis of FDA approval - i read in above articale that UK may take another 2 years to approve. this looks depressing because some patients who r in early stage now - which this new medicine targets - may proceed to later stages by the time medicine here gets approved.
The trials were stopped because the drug was not shown to have any beneficial effect. Then the drug company decided to 're-assess' the data and managed to come up with enough 'evidence' to convince the FDA though this drug is very controversial and many experts disagree with the new, so-called results.
You should also know that it is very expensive and that only people on the highest dose showed any difference at all. (Patients need a fortnightly transfusion.) Added to that the drug has major side effects: 40% of the people on this high dose suffered brain swelling!!!
In short, it needs a lot more research and the FDA really shouldn't have approved it. But there's a lot of money to be made for any company that can produce an effective dementia drug....
I was watching the American news program PBS a few days ago and the 'expert' guest they had on said that it should never have been approved. Side effects can include dementia like symptoms so according to him, that is a good reason not to use it.
We have been hearing about this drug for years. Why now?